Longatto-Filho A - Search Results

1

Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?

Lima L, Dinis-Ribeiro M, Longatto-Filho A, Santos L. Lima L, et al. Adv Urol. 2012;2012:232609. doi: 10.1155/2012/232609. Epub 2012 Aug 7. Adv Urol. 2012. PMID: 22919375 Free PMC article.

2

The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.

Afonso J, Santos LL, Amaro T, Lobo F, Longatto-Filho A. Afonso J, et al. Histopathology. 2009 Nov;55(5):514-24. doi: 10.1111/j.1365-2559.2009.03425.x. Histopathology. 2009. PMID: 19912357

3

CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis.

Afonso J, Longatto-Filho A, Baltazar F, Sousa N, Costa FE, Morais A, Amaro T, Lopes C, Santos LL. Afonso J, et al. Eur J Surg Oncol. 2011 Sep;37(9):811-7. doi: 10.1016/j.ejso.2011.06.006. Epub 2011 Jul 5. Eur J Surg Oncol. 2011. PMID: 21733655 Free article.

4

Low RKIP expression associates with poor prognosis in bladder cancer patients.

Afonso J, Longatto-Filho A, Martinho O, Lobo F, Amaro T, Reis RM, Santos LL. Afonso J, et al. Virchows Arch. 2013 Apr;462(4):445-53. doi: 10.1007/s00428-013-1388-2. Epub 2013 Mar 6. Virchows Arch. 2013. PMID: 23462986

5

Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients.

Afonso J, Longatto-Filho A, DA Silva VM, Amaro T, Santos LL. Afonso J, et al. Oncol Lett. 2014 Oct;8(4):1447-1454. doi: 10.3892/ol.2014.2392. Epub 2014 Jul 30. Oncol Lett. 2014. PMID: 25202348 Free PMC article.

6

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.

Afonso J, Santos LL, Miranda-Gonçalves V, Morais A, Amaro T, Longatto-Filho A, Baltazar F. Afonso J, et al. Mol Carcinog. 2015 Nov;54(11):1451-66. doi: 10.1002/mc.22222. Epub 2014 Sep 27. Mol Carcinog. 2015. PMID: 25263481

7

Stage at presentation of breast cancer in Luanda, Angola - a retrospective study.

Lopes LV, Miguel F, Freitas H, Tavares A, Pangui S, Castro C, Lacerda GF, Longatto-Filho A, Weiderpass E, Santos LL. Lopes LV, et al. BMC Health Serv Res. 2015 Oct 15;15:471. doi: 10.1186/s12913-015-1092-9. BMC Health Serv Res. 2015. PMID: 26471845 Free PMC article.

8

Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness.

Afonso J, Santos LL, Morais A, Amaro T, Longatto-Filho A, Baltazar F. Afonso J, et al. Cell Cycle. 2016;15(3):368-80. doi: 10.1080/15384101.2015.1121329. Epub 2015 Dec 4. Cell Cycle. 2016. PMID: 26636903 Free PMC article.

9

Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Afonso J, Santos LL, Longatto-Filho A, Baltazar F. Afonso J, et al. Nat Rev Urol. 2020 Feb;17(2):77-106. doi: 10.1038/s41585-019-0263-6. Epub 2020 Jan 17. Nat Rev Urol. 2020. PMID: 31953517 Review.

10

Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.

Afonso J, Gonçalves C, Costa M, Ferreira D, Santos L, Longatto-Filho A, Baltazar F. Afonso J, et al. Cancers (Basel). 2023 Feb 3;15(3):982. doi: 10.3390/cancers15030982. Cancers (Basel). 2023. PMID: 36765947 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters